Giving life a better chance

2024-06-14

Pluristem Therapeutics Inc. (Nasdaq:PSTI) is a bio-therapeutics company dedicated to the commercialization of unrelated donor-patient (allogeneic) cell therapy products, derived from human placenta,for the treatment of several severe ischemic and autoimmune disorders.

Pluristem aims to become a leader in stem cell expansion, specializing initially in hematopoietic stem cells, using its unique 3-D technology platform and proprietary bioreactor.